Literature DB >> 11936870

Translational errors as an early event in prion conversion.

I Hatin1, L Bidou, C Cullin, J P Rousset.   

Abstract

A prion is an infectious, altered form of a cellular protein which can self-propagate and affect normal phenotype. Prion conversion has been observed for mammalian and yeast proteins but molecular mechanisms that trigger this process remain unclear. Up to now, only post-translational models have been explored. In this work, we tested the hypothesis that co-translational events may be implicated in the conformation changes of the Ure2p protein of Saccharomyces cerevisiae. This protein can adopt a prion conformation leading to an [URE3] phenotype which can be easily assessed and quantified. We analyzed the effect of two antibiotics, known to affect translation, on [URE3] conversion frequency. For cells treated with G418 we observed a parallel increase of translational errors rate and frequency of [URE3] conversion. By contrast, cycloheximide which was not found to affect translational fidelity, has no influence on the induction of [URE3] phenotype. These results raise the possibility that the mechanism of prion conversion might not only involve alternative structures of strictly identical molecules but also aberrant proteins resulting from translational errors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11936870

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

Review 1.  Stress and prions: lessons from the yeast model.

Authors:  Yury O Chernoff
Journal:  FEBS Lett       Date:  2007-05-08       Impact factor: 4.124

Review 2.  Prion stability.

Authors:  Brian S Cox; Lee J Byrne; Mick F Tuite
Journal:  Prion       Date:  2007-07-06       Impact factor: 3.931

Review 3.  Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery.

Authors:  Tatiana A Chernova; Yury O Chernoff; Keith D Wilkinson
Journal:  Molecules       Date:  2019-09-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.